UBS issued a new 8.50% p.a. USD Early Redemption Kick-In GOAL on Worst of Nasdaq 100 / Russell 2000 / S&P 500 / S&P/TSE 60 (Valor 11406457) directly in the secondary market.
Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.
Anmelden oder
Jetzt abonnieren!
Archiv: Alle Kategorien
UBS issued a new 7.00% p.a. CHF Early Redemption Kick-In GOAL on Worst of Euro STOXX 50 / Nikkei 225 / SMI / S&P 500 (Valor 19946174) directly in the secondary market.
IN SUBSCRIPTION: JB Callable Multi Barrier Reverse Convertibles auf Versorger- und Goldminen-Aktien
» Report
Credit Suisse: Products in Subscription
» Report
Novartis announces update to company's Board of Directors to take effect in February 2013
» Report
Richemont: Changes to senior management
» Report
Partners Group: Accelerated book built offering priced at CHF 183 per share allowing Partners Group founders to invest a minimum of CHF 300 million alongside clients and to materially increase the free float
» Report
Richemont announces its unaudited consolidated results for the six month period ended 30 September 2012
» Report
“Novartis is focused on innovation to address unmet medical needs for patients,” said Joe Jimenez, CEO, at R&Dday
» Report
Mario Draghi, President of the ECB: Introductory statement to the press conference
» Report
Neuemission ZKB Strukturierte Produkte
» Report
EZB PRESSEMITTEILUNG: Geldpolitische Beschlüsse
» Report
Bank of England maintains Bank Rate at 0.5% and the size of the Asset Purchase Programme at £375 billion
» Report
Zurich - News Release: Isabelle Welton appointed Group Chief Marketing Officer
» Report
BLW - Die Bevölkerung steht zur Schweizer Landwirtschaft
» Report
KOF/KOF Konjunkturumfragen vom Oktober: Schlechtere Geschäftslage bei Schweizer Unternehmen
» Report
Nestlé opens first research and development centre in India
» Report
Schweiz: UBS senkt BIP-Prognose 2013 auf 0,9% von 1,4%
» Report
Swisscom: Neue Mobilfunkangebote sehr erfolgreich - Schweizer Geschäft insgesamt leicht rückläufig – höhere Investitionen – Fastweb auf Kurs
» Report
Novartis future growth prospects secured by industry-leading pipeline, with more than 139 projects with 73 new compounds
» Report
